CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects

Summary

To assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single and multiple ascending oral doses of CKD-504 compared to placebo in healthy Korean and Caucasian adult subjects

Timeline

Start

2018-05-23

Primary completion

2020-12

Completion

2020-12

Drugs

Indications